Prophylactic eff ect of fondaparinux and enoxaparin for preventing pulmonary embolism after total hip or knee arthroplasty: A retrospective observational study using the japanese diagnosis procedure combination database

Modern Rheumatology

Volumn 25, Issue 4, 2015, Pages 625-629

  Shoda, Naoko ^a   Yasunaga, Hideo ^a   Horiguchi, Hiromasa ^a   Fushimi, Kiyohide ^b   Matsuda, Shinya ^c   Kadono, Yuho ^a   Tanaka, Sakae ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Enoxaparin; Fondaparinux; Pulmonary embolism; Total hip arthroplasty; Total knee arthroplasty

Indexed keywords

ACETYLSALICYLIC ACID; ENOXAPARIN; FONDAPARINUX; HEPARIN; WARFARIN; ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 10; POLYSACCHARIDE;

ADULT; AGED; ANESTHESIA; ARTICLE; CHARLSON COMORBIDITY INDEX; COMORBIDITY; CONTROLLED STUDY; DATA BASE; DRUG EFFECT; FEMALE; HIP ARTHROPLASTY; HOSPITALIZATION; HUMAN; JAPANESE DIAGNOSIS PROCEDURE COMBINATION DATA BASE; KNEE ARTHROPLASTY; LENGTH OF STAY; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBSERVATIONAL STUDY; OSTEOARTHRITIS; PRIORITY JOURNAL; PROPHYLAXIS; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; RISK FACTOR; VERY ELDERLY; ADVERSE EFFECTS; CLINICAL TRIAL; DIAGNOSTIC IMAGING; FACTUAL DATABASE; HIP REPLACEMENT; JAPAN; KNEE REPLACEMENT; MULTICENTER STUDY; ODDS RATIO; POSTOPERATIVE COMPLICATIONS; PROCEDURES; PULMONARY EMBOLISM; STATISTICS AND NUMERICAL DATA;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; DATABASES, FACTUAL; DIAGNOSTIC IMAGING; ENOXAPARIN; FACTOR X; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; ODDS RATIO; POLYSACCHARIDES; POSTOPERATIVE COMPLICATIONS; PULMONARY EMBOLISM; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84934917286     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.3109/14397595.2014.997424     Document Type: Article

References (29)

1. Jacobs JJ, Mont MA, Bozic KJ, Della Valle CJ, Goodman SB, Lewis CG, et al. American academy of orthopaedic surgeons clinical practice guideline on: preventing venous thromboembolic disease in patients undergoing elective hip and knee arthroplasty. J Bone Joint Surg Am. 2012;94(8):746–7.
2. National Institute for Clinical Excellence. Venous thromboembolism: reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in inpatients undergoing surgery [http://www.nice.org.uk/Guidance/CG46].
3. Japanese Guideline for Prevention of Venous Thromboembolism: Digest [http://www.medicalfront.biz/html/06-books/01_guideline/].
4. Jameson SS, Bottle A, Malviya A, Muller SD, Reed MR. The impact of national guidelines for the prophylaxis of venous thromboembolism on the complications of arthroplasty of the lower limb. J Bone Joint Surg Br. 2010;92(1):123–9.
5. Poultsides LA, Gonzalez Della Valle A, Memtsoudis SG, Ma Y, Roberts T, Sharrock N, et al. Meta-analysis of cause of death following total joint replacement using diff erent thromboprophylaxis regimens. J Bone Joint Surg Br. 2012;94(1):113–21.
6. Sharrock NE, Gonzalez Della Valle A, Go G, Lyman S, Salvati EA. Potent anticoagulants are associated with a higher all-cause mortality rate after hip and knee arthroplasty. Clin Orthop Relat Res. 2008;466(3):714–21.
7. Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133(6 Suppl):381S–453S.
8. Kadono Y, Yasunaga H, Horiguchi H, Hashimoto H, Matsuda S, Tanaka S, et al. Statistics for orthopedic surgery 2006–2007: data from the Japanese Diagnosis Procedure Combination database. J Orthop Sci. 2010;15(2):162–70.
9. Nagase Y, Yasunaga H, Horiguchi H, Hashimoto H, Shoda N, Kadono Y, Nakamura K. Risk factors for pulmonary embolism and the eff ects of fondaparinux after total hip and knee arthroplasty: a retrospective observational study with use of a national database in Japan. J Bone Joint Surg Am. 2011;93(24):e146.
10. Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi JC, et al. Coding algorithms for defi ning comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43(11):1130–9.
11. Hubbard AE, Ahern J, Fleischer NL, Van der Laan M, Lippman SA, Jewell N, et al. To GEE or not to GEE: comparing population average and mixed models for estimating the associations between neighborhood risk factors and health. Epidemiology. 2010;21(4): 467–74.
12. Huang J, Cao Y, Liao C, Wu L, Gao F. Apixaban versus enoxaparin in patients with total knee arthroplasty. A meta-analysis of randomised trials. Thromb Haemost. 2011;105(2):245–53.
13. Khatod M, Inacio MC, Bini SA, Paxton EW. Prophylaxis against pulmonary embolism in patients undergoing total hip arthroplasty. J Bone Joint Surg Am. 2011;93(19):1767–72.
14. Lassen MR, Gallus A, Raskob GE, Pineo G, Chen D, Ramirez LM. Apixaban versus enoxaparin for thromboprophylaxis after hip replacement. N Engl J Med. 2010;363(26):2487–98.
15. Pedersen AB, Mehnert F, Johnsen SP, Husted S, Sorensen HT. Venous thromboembolism in patients having knee replacement and receiving thromboprophylaxis: a Danish population-based follow-up study. J Bone Joint Surg Am. 2011;93(14):1281–7.
16. Bin Abd Razak HR, Soon AT, Dhanaraj ID, Tan AH. Incidence of clinically signifi cant venous thromboembolic events in Asian patients undergoing total knee arthroplasty without anticoagulation. J Arthroplasty. 2012;27(6):1128–32.
17. Kang BJ, Lee YK, Kim HJ, Ha YC, Koo KH. Deep venous thrombosis and pulmonary embolism are uncommon in East Asian patients after total hip arthroplasty. Clin Orthop Relat Res. 2011; 469(12): 3423–8.
18. Fuji T, Fujita S, Ochi T. Fondaparinux prevents venous thromboembolism after joint replacement surgery in Japanese patients. Int Orthop. 2008; 32(4):443–51.
19. Fuji T, Ochi T, Niwa S, Fujita S. Prevention of postoperative venous thromboembolism in Japanese patients undergoing total hip or knee arthroplasty: two randomized, double-blind, placebo-controlled studies with three dosage regimens of enoxaparin. J Orthop Sci. 2008;13(5):442–51.
20. Yokote R, Matsubara M, Hirasawa N, Hagio S, Ishii K, Takata C. Is routine chemical thromboprophylaxis after total hip replacement really necessary in a Japanese population? J Bone Joint Surg Br. 2011;93(2):251–6.
21. White RH, Gettner S, Newman JM, Trauner KB, Romano PS.Predictors of rehospitalization for symptomatic venous thromboembolism after total hip arthroplasty. N Engl J Med. 2000;343(24):1758–64.
22. Schiff RL, Kahn SR, Shrier I, Strulovitch C, Hammouda W, Cohen E, Zukor D. Identifying orthopedic patients at high risk for venous thromboembolism despite thromboprophylaxis. Chest. 2005;128(5):3364–71.
23. Mantilla CB, Horlocker TT, Schroeder DR, Berry DJ, Brown DL. Risk factors for clinically relevant pulmonary embolism and deep venous thrombosis in patients undergoing primary hip or knee arthroplasty. Anesthesiology. 2003;99(3):552–60; discussion 555A.
24. Pedersen AB, Sorensen HT, Mehnert F, Overgaard S, Johnsen SP. Risk factors for venous thromboembolism in patients undergoing total hip replacement and receiving routine thromboprophylaxis. J Bone Joint Surg Am. 2010;92A(12):2156–64.
25. Choi HK, Rho YH, Zhu Y, Cea-Soriano L, Avina-Zubieta JA, Zhang Y. The risk of pulmonary embolism and deep vein thrombosis in rheumatoid arthritis: a UK population-based outpatient cohort study. Ann Rheum Dis. 2012.
26. Zoller B, Li X, Sundquist J, Sundquist K. Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden. Lancet. 2012;379(9812):244–9.
27. Ramagopalan SV, Wotton CJ, Handel AE, Yeates D, Goldacre MJ. Risk of venous thromboembolism in people admitted to hospital with selected immune-mediated diseases: record-linkage study. BMC Med. 2011;9:1.
28. Niki Y, Matsumoto H, Hakozaki A, Mochizuki T, Momohara S. Rheumatoid arthritis: a risk factor for deep venous thrombosis after total knee arthroplasty? Comparative study with osteoarthritis. J Orthop Sci. 2010;15(1):57–63.
29. Yoshitaka T, Abe N, Minagawa H, Date H, Sakoma Y, Nishida K, Ozaki T. Disease-specifi c screening for deep venous thrombosis and pulmonary thromboembolism using plasma D-dimer values after total knee arthroplasty. Mod Rheumatol. 2008;18(4):359–65.